Xcorporeal PE Ratio 2010-2009 | XCRP
Current and historical p/e ratio for Xcorporeal (XCRP) from 2010 to 2009. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Xcorporeal PE ratio as of April 26, 2024 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Xcorporeal PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 0.00 | nan | ||
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.000B | $0.000B |
| Xcorporeal, Inc. it operated as a medical device company, which was engaged in the development of an extra-corporeal platform technology to be used in devices to replace the function of various human organs. The platforms lead to three initial products: portable artificial kidney (PAK), for attended care renal replacement therapy (RRT), for patients suffering from acute renal failure (ARF); a PAK for home hemodialysis for patients suffering from end stage renal disease (ESRD), and a wearable artificial kidney (WAK) for continuous ambulatory hemodialysis for treatment of ESRD. The PAK for the attended care market is a portable, multifunctional renal replacement device that would offer therapy for those patients suffering from ARF, causing a rapid decline in kidney function. The PAK for the home hemodialysis market is a device for patients suffering from ESRD, in whom the kidneys have ceased to function. The WAK is a device for the chronic treatment of ESRD. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $218.237B | 26.44 |
| Intuitive Surgical (ISRG) | United States | $132.348B | 79.73 |
| DexCom (DXCM) | United States | $54.655B | 83.14 |
| Edwards Lifesciences (EW) | United States | $52.976B | 34.51 |
| IQVIA Holdings (IQV) | United States | $42.467B | 25.19 |
| IDEXX Laboratories (IDXX) | United States | $40.633B | 48.58 |
| Alcon (ALC) | Switzerland | $38.876B | 28.67 |
| STERIS (STE) | Ireland | $19.915B | 23.57 |
| Waters (WAT) | United States | $18.288B | 26.24 |
| Hologic (HOLX) | United States | $17.772B | 19.61 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.481B | 0.00 |
| ShockWave Medical (SWAV) | United States | $12.303B | 85.01 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $11.860B | 14.65 |
| Sysmex ADR (SSMXY) | Japan | $9.975B | 31.28 |
| Teleflex (TFX) | United States | $9.736B | 15.29 |
| Penumbra (PEN) | United States | $7.965B | 98.32 |
| Masimo (MASI) | United States | $7.156B | 40.13 |
| Globus Medical (GMED) | United States | $6.819B | 21.62 |
| Glaukos (GKOS) | United States | $5.024B | 0.00 |
| Integer Holdings (ITGR) | United States | $3.724B | 22.50 |
| LivaNova (LIVN) | United Kingdom | $2.973B | 19.61 |
| TransMedics (TMDX) | United States | $2.920B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $2.687B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $2.570B | 17.63 |
| Nihon Kohden (NHNKY) | Japan | $2.380B | 20.13 |
| Tandem Diabetes Care (TNDM) | United States | $2.296B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $2.233B | 9.16 |
| Inari Medical (NARI) | United States | $2.207B | 380.70 |
| RxSight (RXST) | United States | $1.919B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.689B | 0.00 |
| Veracyte (VCYT) | United States | $1.462B | 0.00 |
| OPKO Health (OPK) | United States | $0.850B | 0.00 |
| Artivion (AORT) | United States | $0.835B | 96.52 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.825B | 15.26 |
| Paragon 28 (FNA) | United States | $0.744B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.712B | 0.00 |
| Silk Road Medical (SILK) | United States | $0.691B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.636B | 0.00 |
| SiBone (SIBN) | United States | $0.586B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.549B | 18.65 |
| IRadimed (IRMD) | United States | $0.525B | 30.49 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.490B | 0.00 |
| Nevro (NVRO) | United States | $0.426B | 0.00 |
| NeuroPace (NPCE) | United States | $0.373B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.370B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.369B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.339B | 11.42 |
| CVRx (CVRX) | United States | $0.311B | 0.00 |
| AxoGen (AXGN) | United States | $0.285B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.275B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.255B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.232B | 0.00 |
| Accuray (ARAY) | United States | $0.216B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.190B | 0.00 |
| 908 Devices (MASS) | United States | $0.183B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.182B | 9.81 |
| Alpha Tau Medical (DRTS) | Israel | $0.167B | 0.00 |
| Inogen (INGN) | United States | $0.153B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.144B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.134B | 0.00 |
| Yubo Biotech (YBGJ) | China | $0.112B | 0.00 |
| Neuronetics (STIM) | United States | $0.106B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.100B | 0.00 |
| Envoy Medical (COCH) | United States | $0.099B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.093B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.075B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.070B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.063B | 0.00 |
| Hyperfine (HYPR) | United States | $0.060B | 0.00 |
| SEP Acquisition (SEPA) | United States | $0.058B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.055B | 111.00 |
| Vasomedical (VASO) | United States | $0.052B | 9.33 |
| Vicarious Surgical (RBOT) | United States | $0.046B | 0.00 |
| InspireMD (NSPR) | Israel | $0.045B | 0.00 |
| DarioHealth (DRIO) | United States | $0.044B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.040B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.040B | 0.00 |
| ReWalk Robotics (LFWD) | Israel | $0.040B | 0.00 |
| LENSAR (LNSR) | United States | $0.039B | 0.00 |
| Pixie Dust Technologies (PXDT) | Japan | $0.038B | 0.00 |
| Precision Optics (POCI) | United States | $0.034B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.032B | 0.00 |
| Spectral AI (MDAI) | United States | $0.032B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.024B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.023B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.020B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.017B | 0.00 |
| PAVmed (PAVM) | United States | $0.016B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.015B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.015B | 0.00 |
| NexGel (NXGL) | United States | $0.014B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.013B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.012B | 0.00 |
| Avinger (AVGR) | United States | $0.006B | 0.00 |
| Venus Concept (VERO) | Canada | $0.005B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.004B | 0.00 |
| Dynatronics (DYNT) | United States | $0.003B | 0.00 |
| Tenon Medical (TNON) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |